P.O. Box 50030 London, ON N6A 6H8 info@rett.ca (519) 474-6877

Priority Review by Health Canada

Just announced at the 2024 Ascend Rett National Conference, Health Canada has accepted regulatory applications from Acadia Pharmaceuticals for DayBue (Trofinetide), but has also been accepted for a priority review by Health Canada.

We were honored to be mentioned by Acadia Pharmaceuticals.

See the video below.